Metastatic urothelial carcinoma PD-L1 expression, Cancer Genome Atlas subtype, and mutational load as independent predictors of response to atezolizumab

Clinical trials - lung cancer, head and neck cancers - new ways, further developments of treatment, combinations

ASCO/ECCO Joint session: Value Based Care

CheckMate-032: Phase I/II, open-label study of safety and activity of nivolumab alone or with ipilimumab in advanced and metastatic gastric cancer

US: Progress in Myeloproliferative Neoplasms

Long-term OS for patients with advanced NSCLC enrolled in the KEYNOTE-001 study of pembrolizumab

Management of Acute Lymphoblastic Leukemia

Safety and antitumor activity of hypofractionated stereotactic irradiation with pembrolizumab and bevacizumab in patients with recurrent high grade gliomas: Preliminary result

Advances in the treatment of head and neck cancers - combination: radiation and immunotherapy

Breast Cancer-Triple Negative/Cytotoxics/Local Therapy - Breast cancer highlights of ASCO 2016

Novel agents in Non-Hodgkin Lymphoma, in CNS involvment, in Limited-Stage Hodgkin Lymphoma

Nivolumab ± ipilimumab in treatment of patients with metastatic colorectal cancer with and without high microsatellite instability: CheckMate-142 interim results

US: Trends, most important results at ASCO 2016 - Immunotherapy, checkpoint inhibitors, targeted therapies, brain tumor